N-α-Boc-L-lysine

N-α-Boc-L-lysine is an L-lysine amino acid derivative in which the α-amino group is protected as a Boc carbamate, while the ε-amino side chain remains unprotected and protonatable. The molecule contains a free carboxylic acid and a stereogenic center at the α-carbon, preserving the L-configuration relevant to peptide coupling and stereochemically controlled synthesis. The Boc group provides acid-labile protection for selective Nα chemistry, whereas the ε-amine can participate in nucleophilic acylation, reductive amination, or further protection strategies depending on the target sequence. As a chiral amino acid intermediate and peptide building block precursor, N-α-Boc-L-lysine supports downstream formation of protected lysine residues, side-chain functionalized analogs, and chemically defined intermediates for fine chemical and biochemical workflows.

1. Peptide Synthesis

N-α-Boc-L-lysine is applied in peptide synthesis workflows where lysine residues require orthogonal protection to manage chemoselectivity during N- and side-chain functionalization. The Boc-protected α-amino group enables controlled peptide coupling at the α-position, while the free ε-amino side chain can be selectively protected (e.g., as an orthogonal carbamate or acyl group) prior to or during chain assembly. The carboxylic acid functionality participates in standard peptide coupling chemistry after conversion to an activated acid derivative, supporting incorporation into linear peptides and protected peptide fragments. Downstream, the resulting lysine-containing peptides can be used for sequence-dependent studies, fragment ligation, and preparation of lysine-rich scaffolds that retain defined side-chain reactivity for subsequent conjugation.

2. Side-Chain Functionalization

N-α-Boc-L-lysine is used for side-chain functionalization in synthetic organic chemistry and chemical biology, leveraging the unprotected ε-amine as a reactive handle for derivatization. The ε-amino group enables formation of amide linkages, urea/thiourea motifs, sulfonamides, or amine-reactive conjugates, while the Boc carbamate maintains the α-amino group in a protected state to prevent undesired cross-reactions. The L-lysine stereocenter and free carboxylic acid support further transformations such as esterification for solubility control or conversion to activated intermediates for coupling to biomolecules and polymers. Generated derivatives serve as intermediates for peptidomimetics, labeled lysine analogs, and chemically defined materials where controlled ε-functional group placement is required.

3. Protected Amino Acid Chemistry

N-α-Boc-L-lysine is suitable for protected amino acid synthesis and orthogonal protection design, acting as a chiral lysine precursor with an acid-labile Nα protecting group. The Boc group stabilizes the α-amino functionality during side-chain modification, allowing sequential protection strategies that can be tuned to the planned peptide assembly method and deprotection schedule. The free carboxylic acid can be transformed into esters or activated acids to support intermediate preparation for automated peptide synthesis, while the ε-amine can be selectively protected to generate fully protected lysine building blocks when needed. Downstream use includes preparation of lysine derivatives for sequence construction, synthesis of lysine-based standards, and manufacturing-relevant routing of protected amino acid intermediates with predictable chemoselectivity.

4. Chemical Biology And Bioconjugation

N-α-Boc-L-lysine is applied in chemical biology and bioconjugation chemistry to create lysine-containing linkers, probes, and conjugation-ready intermediates with controlled stereochemistry. The ε-amino side chain can be coupled to electrophilic tags, affinity handles, or reporter groups through amide-forming or reductive amination pathways, while the Boc-protected α-amino group helps maintain structural integrity during probe assembly. The carboxylic acid enables formation of conjugation-ready esters or activated derivatives that can be used to connect lysine-based fragments to larger biomolecular constructs. Generated conjugates can serve as defined reagents for studying molecular interactions, labeling strategies, and structure-dependent behavior of lysine-bearing motifs in biochemical assays.

5. Pharmaceutical Intermediate Preparation

N-α-Boc-L-lysine is utilized in pharmaceutical intermediate preparation and process chemistry contexts where controlled functional group protection is required for downstream synthesis of peptide-like or amine-rich intermediates. The Boc carbamate provides a predictable protection element for Nα handling, while the free ε-amine supports further conversion into amide, urea, or protected amine forms that can match synthetic requirements for active ingredient scaffolds or formulation-related intermediates. The presence of both carboxylic acid and amine functionalities enables route design that can incorporate esterification, activation, and selective deprotection steps without losing the stereochemical identity of the L-lysine core. Downstream, the compound can be converted into protected lysine building blocks, side-chain functionalized amine intermediates, and process-compatible reagents for specialty chemical production where reproducible chemoselectivity is required.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. GLP-1, exendin-4 and C-peptide regulate pancreatic islet microcirculation, insulin secretion and glucose tolerance in rats

3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide